Review of past and present clinical cases with a view to future treatment options.

Related Articles

Review of past and present clinical cases with a view to future treatment options.

Future Oncol. 2017 May 02;:

Authors: Martín-Broto J, Reichardt P, Stacchiotti S, Blay JY

Abstract
In the 10 years that have elapsed since trabectedin was first granted approval in Europe for treatment of advanced soft tissue sarcoma (STS), other cytotoxic agents and targeted therapies have been approved and numerous randomized controlled trials have been completed or are underway. As an academic exercise and positive proof of the advances in STS management that have occurred during the past decade, it is interesting to compare current and future treatment approaches. In this review, present and future treatment approaches are examined by case study for three STS subtypes: uterine leiomyosarcoma, abdominal dedifferentiated liposarcoma and malignant solitary fibrous tumor.

PMID: 28460536 [PubMed - as supplied by publisher]

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2q1RAhe
via IFTTT